![](https://flagship-pioneering.transforms.svdcdn.com/production/newcos/20240108_Flagship_SF-299.jpg?w=300&h=300&auto=compress%2Cformat&fit=crop&crop=focalpoint&fp-x=0.5921&fp-y=0.2958&dm=1704998947&s=92f9772306d2a41cc49326768d76a884)
ProFound™ Therapeutics
ProFound™ Therapeutics is pioneering the discovery of a vastly expanded human proteome and using its newfound insights to unlock a universe of potential new medicines. The company’s ProFoundry™ Platform uses state-of-the-art protein detection technologies to systematically identify and validate proteins and dissect their therapeutic potential. The result is an ever-expanding database of tens of thousands of novel proteins, including their connectivity, functionality, and roles in health and disease. ProFound Therapeutics was founded in 2020 at Flagship Labs, a unit of Flagship Pioneering.
Latest News from ProFound™ Therapeutics
- Flagship Pioneering and ProFound Therapeutics Announce Agreement to Identify Novel First-in-Class Therapeutics for the Treatment of Obesity under Strategic Partnership with Pfizer 06.12.2024
- Flagship Pioneering Appoints John Lepore as CEO-Partner and CEO of ProFound Therapeutics 10.02.2023
- Flagship Pioneering Unveils ProFound™ Therapeutics to Illuminate an Expanded Universe of Human Proteins with the Potential to Enable a Multitude of New Medicines 05.26.2022